ORLANDO, Fla., May 07, 2026 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today announced it will release its first quarter 2026 financial results after market close on Thursday, May 14, 2026. Management will host a conference call on the day of the release at 5:00 pm ET to discuss the results. The event will be webcasted live via our investor relations website https://ir.innventure.com/ or via this link. A replay of the event webcast will be made available on Innventure’s Investor Relations website following the call. About InnventureInnventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, focuses on building companies with billion-dollar valuations by commercializing breakthrough technology solutions. By systematically creating and operating industrial enterprises...

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinical engagement, and continued development of its commercial and reimbursement infrastructure. Advisor Program Driving Utilization and Real-World Data Generation Since launching the CompuFlo® Advisor Program in February 2026, the Company has onboarded physician advisors and initiated procedural use across key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast Service Options, and Palmetto, as well as select commercial payers. The program is currently active in NJ, FL, PA, NY, TN, TX, and GA, with expansion into...

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) — Nightfood Holdings Inc. (OTCQB: NGTF) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Service Robotics Rise Transforms How Businesses Operate,” please visit: https://ibn.fm/znCAS Demand for service robotics is accelerating worldwide as organizations increasingly adopt automation to manage workforce shortages, rising operating expenses and efficiency challenges. According to the International Federation of Robotics, adoption continues to broaden across industries, with hundreds of...

VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) (“GoldHaven” or the “Company”) is pleased to announce that, due to strong investor demand, it has increased the size of its previously announced flow-through non-brokered financing to gross proceeds of up to $1,200,000 (the “Offering”). The additional capital further strengthens the Company’s fully funded 2026 exploration program at its flagship Magno Project in the Cassiar District of British Columbia and is expected to support an expanded drill campaign targeting a large-scale, multi-phase mineral system with significant silver and critical metals exposure. HIGHLIGHTSFinancing Upsized on Demand: Increased to up to $1.2 million, reflecting strong investor demand Drilling Expansion Underway: Program expected...

Miami, FL, May 07, 2026 (GLOBE NEWSWIRE) — MARA Holdings, Inc. (NASDAQ: MARA) (“MARA”) today announced that MARA USA Corporation, its wholly owned subsidiary (the “Offeror”), has commenced a consent solicitation (the “Consent Solicitation”) to amend the indenture (the “Indenture”) governing the outstanding notes of Long Ridge Energy LLC (the “Issuer”), as set forth in the table below (the “Notes”). The terms and conditions of the Consent Solicitation are set forth in a consent solicitation statement dated as of May 7, 2026 (as it may be amended and supplemented from time to time, the “Consent Solicitation Statement”).Title of Notes CUSIP Numbers Aggregate Principal Amount Outstanding Consent Fee(1)8.750% Senior Secured Notes due 2032 54288CAA1U5423CAA6 $600,000,000 $2.50(1) For each $1,000 principal amount of the Notes. Amendment...

Draganfly IncDrone Makers ACSL and Draganfly Partner to Bring NDAA-Compliant Japanese Drones to Canadian MarketCollaboration Enables Cross-Platform, NDAA-Compliant Interoperability, Expanding Fleet Access and Capabilities for Public Safety and Industry Vancouver, B.C., May 07, 2026 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer and ACSL, the largest Japanese drone maker, renowned for innovation and commitment to quality, have signed an exclusive master distributor agreement and launched technology integrations. This partnership will bring ACSL’s technology to the Canadian market while the resulting collaboration will lead to the development of exciting new capabilities and interoperability between...

The Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strategies Targeting TBI-Induced Inflammation on Both Sides of the Blood-Brain Barrier Sarasota, FL and San Diego, CA, May 07, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a clinical-stage biopharmaceutical company pioneering neurological therapeutics, and Sigyn Therapeutics, Inc. (OTCQB: SIGY) (“Sigyn”), a developer of extracorporeal therapies, today announced the signing of a Letter of Intent (“LOI”) under which Oragenics expects to license from Sigyn, certain disease indications of CardioDialysis™, a blood purification technology that enables the broad-spectrum clearance of inflammatory and pathogenic molecules from the bloodstream. Under the terms...

– Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome – Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Confirmed QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Review – U.S. FDA Granted Fast Track Designation to QRX003 lotion (4%) for the treatment of Netherton Syndrome, Complementing Previously Granted Orphan Drug and Rare Pediatric Disease Designations – Constructive Type C Meeting with FDA: Single Phase 3 Study May Be Sufficient to Support U.S. Marketing Approval; FDA Open to Trial Design Without Traditional Vehicle or Placebo Control – Rare Pediatric Disease Priority Review Voucher Program Extended by Congress Through September 30, 2029 – On Track to Complete Phase 3 Patient Recruitment by End of 2026, with Potential NDA...

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) — CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the filing of a new Substance of Matter (SOM) patent covering two established compounds within the cystic fibrosis market. Sarborg announced that the patent was developed using its proprietary Signature Agent and Multi-Agent platform, supported by its Sarborg 1,600 Disease Database and Sarborg 1,700 Rare Disease Database. According to Sarborg, this approach enables rapid identification of new therapeutic opportunities, including additional indications and combination strategies, with patent filing achieved in less than three weeks. CDT believes this development represents a strong validation of Sarborg’s platform capabilities and its ability...

Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console FORT LAUDERDALE, Fla., May 07, 2026 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of a long-distance cross-border telesurgery utilizing the SSi Mantra surgical robotic system (the “SSi Mantra”) and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) and spanning more than 4,500 miles from the surgeon located at the Royal Australian College of Surgeons in Perth, Australia to the patient in Indore,...